Supplemental material of historical-prospective real-life cohort study on the impact of first-line medical therapy for amiodarone-induced thyrotoxicosis on cardiovascular events and hospitalizations
Data are number of events/(%).- The primary endpoint of this study was 30-day Major Adverse Coronary Events (MACE): all-cause mortality, recurrent MI, recurrent ischemia, stent thrombosis, ischemic st
